FDA doesn't consider mortality to be an important outcome when approving new ABX

Dec 28, 2013 18:35

My notes are behind the cut. These ladies review some recent FDA approvals and critique the process. The upshot is that the FDA is fast-tracking drugs without following their own rules regarding the supposedly scientific and independent review process. My take: Don't Use New RX drugs until they've been on the market at least 10 years. Otherwise ( Read more... )

kidneys, death, microbes, antibiotics, tuberculosis, pharmaceuticals, fda

Leave a comment

Comments 1

anais_pf December 29 2013, 03:46:29 UTC
Oh dear god. Thank you for the warning.

Reply


Leave a comment

Up